» Articles » PMID: 31530563

Steady-state and Regenerative Hematopoiesis Occurs Normally in Mice in the Absence of GDF11

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2019 Sep 19
PMID 31530563
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Tightly regulated production of mature blood cells is essential for health and survival in vertebrates and dependent on discrete populations of blood-forming (hematopoietic) stem and progenitor cells. Prior studies suggested that inhibition of growth differentiation factor 11 (GDF11) through soluble activin receptor type II (ActRII) ligand traps or neutralizing antibodies promotes erythroid precursor cell maturation and red blood cell formation in contexts of homeostasis and anemia. As Gdf11 is expressed by mature hematopoietic cells, and erythroid precursor cell expression of Gdf11 has been implicated in regulating erythropoiesis, we hypothesized that genetic disruption of Gdf11 in blood cells might perturb normal hematopoiesis or recovery from hematopoietic insult. Contrary to these predictions, we found that deletion of Gdf11 in the hematopoietic lineage in mice does not alter erythropoiesis or erythroid precursor cell frequency under normal conditions or during hematopoietic recovery after irradiation and transplantation. In addition, although hematopoietic cell-derived Gdf11 may contribute to the pool of circulating GDF11 protein during adult homeostasis, loss of Gdf11 specifically in the blood system does not impair hematopoietic stem cell function or induce overt pathological consequences. Taken together, these results reveal that hematopoietic cell-derived Gdf11 is largely dispensable for native and transplant-induced blood formation.

Citing Articles

An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.

Upton P, Dunmore B, Li W, Morrell N Dev Dyn. 2022; 252(3):327-342.

PMID: 35434863 PMC: 10952790. DOI: 10.1002/dvdy.478.


The Role of Iron in Benign and Malignant Hematopoiesis.

Sinha S, Pereira-Reis J, Guerra A, Rivella S, Duarte D Antioxid Redox Signal. 2020; 35(6):415-432.

PMID: 33231101 PMC: 8328043. DOI: 10.1089/ars.2020.8155.


Similar sequences but dissimilar biological functions of GDF11 and myostatin.

Suh J, Lee Y Exp Mol Med. 2020; 52(10):1673-1693.

PMID: 33077875 PMC: 8080601. DOI: 10.1038/s12276-020-00516-4.


Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes.

Verma A, Suragani R, Aluri S, Shah N, Bhagat T, Alexander M J Clin Invest. 2020; 130(2):582-589.

PMID: 31961337 PMC: 6994157. DOI: 10.1172/JCI133678.


Variation in zygotic CRISPR/Cas9 gene editing outcomes generates novel reporter and deletion alleles at the Gdf11 locus.

Goldstein J, Valido A, Lewandowski J, Walker R, Mills M, Messemer K Sci Rep. 2019; 9(1):18613.

PMID: 31819086 PMC: 6901511. DOI: 10.1038/s41598-019-54766-y.

References
1.
Ogilvy S, Metcalf D, Gibson L, Bath M, Harris A, Adams J . Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood. 1999; 94(6):1855-63. View

2.
Sinha M, Jang Y, Oh J, Khong D, Wu E, Manohar R . Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014; 344(6184):649-52. PMC: 4104429. DOI: 10.1126/science.1251152. View

3.
Loffredo F, Steinhauser M, Jay S, Gannon J, Pancoast J, Yalamanchi P . Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4):828-39. PMC: 3677132. DOI: 10.1016/j.cell.2013.04.015. View

4.
Pop R, Shearstone J, Shen Q, Liu Y, Hallstrom K, Koulnis M . A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression. PLoS Biol. 2010; 8(9). PMC: 2943437. DOI: 10.1371/journal.pbio.1000484. View

5.
Hammers D, Merscham-Banda M, Hsiao J, Engst S, Hartman J, Sweeney H . Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol Med. 2017; 9(4):531-544. PMC: 5376753. DOI: 10.15252/emmm.201607231. View